Serious haematological toxicity during and after ipilimumab treatment: a case series

INTRODUCTION: Immunotherapy with the anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody ipilimumab has been shown to improve overall survival in previously treated and treatment-naïve patients with unresectable stage III or IV melanoma. Consistent with its proposed immunomodulating mechanism...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Simeone, Ester, Grimaldi, Antonio Maria, Esposito, Assunta, Curvietto, Marcello, Palla, Marco, Paone, Miriam, Mozzillo, Nicola, Ascierto, Paolo Antonio
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4090655/
https://ncbi.nlm.nih.gov/pubmed/24986059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-240
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items